WHO ICTRP trial
The effect of Masport Botulinum toxin injection in reducing the recurrence of…
IRCT20191222045852N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191222045852N1 |
|---|---|
| Public title | The effect of Masport Botulinum toxin injection in reducing the recurrence of bulbar urethral stricture |
| Scientific title | The effect of Botulinum toxin Masport injection following internal urethrotomy indecrease of recurrence of bulbar urethral stricture |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Bulbar Urethral Stricture. Other specified disorders of male genital organs;N50.8 |
| Interventions | Intervention group: men with bulbar stricture who were injected with botulinum toxin type A after surgery.Patients underwent spinal anesthesia and dorsal position lithotomy and underwent direct vision internal urethrotomy (DVIU) after… |
| Registration date | Oct 29, 2023 |
| Target size | 20 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: